EC approves new easy-to-use, once-weekly Bydureon BCise device for patients with type-2 diabetes
AstraZeneca announced that the EC has approved Bydureon BCise as a new formulation within the marketing authorisation for Bydureon for the treatment of patients...
Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab
Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension (LTE) Phase 1b study of aducanumab, an investigational...
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®
Exact Sciences Corp and Pfizer Inc. announced an agreement through 2021 to co-promote Cologuard, the first and only FDA-approved non-invasive stool DNA screening test...
ViiV Healthcare reports positive 48-week results for first pivotal, phase III study for novel, long-acting, injectable HIV-treatment regimen
ViiV Healthcare announced positive headline results from its global, phase III ATLAS study of a long-acting, injectable two-drug regimen (2DR) for the treatment of...
U.S. FDA approves opdivo as the first new medication in nearly 20 years for certain patients with previously treated small cell lung cancer
Bristol-Myers Squibb Company announced that Opdivo (nivolumab) received approval from the U.S. FDA as the first and only Immuno-Oncology treatment option for patients with...
Healthy Interactions and Merck announce launch of digital health platform designed to enhance patient engagement in diabetes management
Healthy Interactions, a global leader in health education, in collaboration with Merck , known as MSD outside the United States and Canada, announced the...
Eisai And Merck announce FDA approval of LENVIMA capsules for first-line treatment of Unresectable Hepatocellular Carcinoma
Eisai Inc. and Merck , known as MSD outside of the United States and Canada , announced that the U.S. FDA approved the kinase...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...